Cardiff Leads $10M Study of Genetic, Lifestyle Factors in Alzheimer's | GenomeWeb

NEW YORK (GenomeWeb News) – Cardiff University scientists will use £6 million ($10 million) in funding to integrate and study genomic and environmental information from more than a million people and create a resource that could lead to new methods for assessing risk and personalized treatments for Alzheimer's disease.

The project aims to examine genetic markers along with lifestyle and dietary data to create "a fuller picture" of why Alzheimer's develops, how it is triggered, and why different individuals face different risks, Cardiff said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.